Discovery and biological evaluation of adamantyl amide 11beta-HSD1 inhibitors

Bioorg Med Chem Lett. 2007 May 15;17(10):2838-43. doi: 10.1016/j.bmcl.2007.02.057. Epub 2007 Feb 25.

Abstract

A series of adamantyl amide 11beta-HSD1 inhibitors has been discovered and chemically modified. Selected compounds are selective for 11beta-HSD1 over 11beta-HSD2 and possess excellent cellular potency in human and murine 11beta-HSD1 assays. Good pharmacodynamic characteristics are observed in ex vivo assays.

Publication types

  • Evaluation Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • 11-beta-Hydroxysteroid Dehydrogenase Type 1 / antagonists & inhibitors*
  • 11-beta-Hydroxysteroid Dehydrogenase Type 2 / antagonists & inhibitors
  • Adamantane / analogs & derivatives*
  • Adamantane / chemistry
  • Adamantane / pharmacology*
  • Amides / chemistry
  • Amides / pharmacology*
  • Animals
  • Enzyme Inhibitors / chemistry
  • Enzyme Inhibitors / pharmacology*
  • Humans
  • Mice
  • Molecular Structure
  • Structure-Activity Relationship

Substances

  • Amides
  • Enzyme Inhibitors
  • 11-beta-Hydroxysteroid Dehydrogenase Type 1
  • 11-beta-Hydroxysteroid Dehydrogenase Type 2
  • Adamantane